Deletion of 13q14, a common cytogenetic aberration in CLL, may partially account for BCL2 up-regulation, because it involves miR-15a and miR-16 loci, both being negative BCL2 regulators [30]. The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.